Search

everythinglearnresearchcommunity

for

Search:↓

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Bacteroides fragilis and Microbacterium sp. T32 may be linked to autoimmune activity in Hashimoto's thyroiditis and alopecia areata.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Alopecia areata and vitiligo can coexist, respond well to treatment, and may have a better prognosis together.

The document concludes that while white skin, nail, and mucosa diseases increase skin cancer risk, they are generally harmless, especially compared to darker pigmentation conditions.

DAVID syndrome is a condition with immune system and hormone deficiencies, needing early diagnosis to avoid serious complications.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatment strategies.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

Satoyoshi syndrome can cause eye problems like uveitis and retinal vein issues.

Treating H. pylori infection might help cure alopecia areata.

Understanding sex and gender differences can improve personalized dermatology care.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Hair follicles prevent NK cell attacks to avoid hair loss.

People with Alopecia Areata have lower vitamin D levels.

Alopecia areata patients may have higher cardiovascular risk factors, so screening for metabolic syndrome components is suggested.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

PCOS involves immune system issues and inflammation, possibly leading to autoimmune diseases.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

CTLA4 gene variants are not linked to alopecia areata in Monterrey's Mexican population.

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Improved oral hygiene and dietary changes can help manage black hairy tongue syndrome.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.